Terms: = Liver cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
38 results:
1. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
2. Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Gerratana L; Davis AA; Velimirovic M; Clifton K; Hensing WL; Shah AN; Dai CS; Reduzzi C; D'Amico P; Wehbe F; Medford A; Wander SA; Gradishar WJ; Behdad A; Puglisi F; Ma CX; Bardia A; Cristofanilli M
Breast Cancer Res; 2023 Oct; 25(1):112. PubMed ID: 37784176
[TBL] [Abstract] [Full Text] [Related]
3. [Preliminary study of PPARA regulate the ferroptosis of hepatocellular carcinoma to prevent disease deterioration].
Cai JJ; Liang MT; Li WQ; Zhang WY; Li X; Sun ZH
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jul; 57(7):1068-1074. PubMed ID: 37482742
[TBL] [Abstract] [Full Text] [Related]
4.
Lu J; Ding Y; Zhang W; Qi Y; Zhou J; Xu N; Zhang Y; Xie W
Cells; 2023 Apr; 12(9):. PubMed ID: 37174639
[TBL] [Abstract] [Full Text] [Related]
5. Protocadherin 20 promotes ferroptosis by suppressing the expression of Sirtuin 1 and promoting the acetylation of nuclear factor erythroid 2-related factor 2 in hepatocellular carcinoma.
Jun L; Chen W; Han L; Yanmin L; Qinglei Z; Pengfei Z
Int J Biochem Cell Biol; 2023 Mar; 156():106363. PubMed ID: 36641129
[TBL] [Abstract] [Full Text] [Related]
6. IGF2BP3-nrf2 axis regulates ferroptosis in hepatocellular carcinoma.
Lu Z; Yang H; Shao Y; Sun W; Jiang Y; Li J
Biochem Biophys Res Commun; 2022 Oct; 627():103-110. PubMed ID: 36030651
[TBL] [Abstract] [Full Text] [Related]
7. The therapeutic role of nutraceuticals targeting the nrf2/HO-1 signaling pathway in liver cancer.
Alharbi KS; Almalki WH; Albratty M; Meraya AM; Najmi A; Vyas G; Singh SK; Dua K; Gupta G
J Food Biochem; 2022 Oct; 46(10):e14357. PubMed ID: 35945911
[TBL] [Abstract] [Full Text] [Related]
8. Identification of novel biomarkers in prostate cancer diagnosis and prognosis.
Li W; Xu W; Sun K; Wang F; Wong TW; Kong AN
J Biochem Mol Toxicol; 2022 Sep; 36(9):e23137. PubMed ID: 35686336
[TBL] [Abstract] [Full Text] [Related]
9. Centrosomal protein 290 is a novel prognostic indicator that modulates liver cancer cell ferroptosis via the
Shan Y; Yang G; Lu Q; Hu X; Qi D; Zhou Y; Xiao Y; Cao L; Tian F; Pan Q
Aging (Albany NY); 2022 Mar; 14(5):2367-2382. PubMed ID: 35271462
[TBL] [Abstract] [Full Text] [Related]
10. The Expression and Prognostic Value of cancer Stem Cell Markers, nrf2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma.
Tseeleesuren D; Hsiao HH; Kant R; Huang YC; Tu HP; Lai CC; Huang SF; Yen CH
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208536
[No Abstract] [Full Text] [Related]
11. Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome.
Li D; Yu T; Hu J; Wu J; Feng S; Xu Q; Zhu H; Zhang X; Zhang Y; Zhou B; Gu L; Zeng Z
Oxid Med Cell Longev; 2021; 2021():5175581. PubMed ID: 35003516
[TBL] [Abstract] [Full Text] [Related]
12. p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities.
Tan CT; Soh NJH; Chang HC; Yu VC
FEBS J; 2023 Feb; 290(4):892-912. PubMed ID: 34882306
[TBL] [Abstract] [Full Text] [Related]
13. The transcriptome of early GGT/KRT19-positive hepatocellular carcinoma reveals a downregulated gene expression profile associated with fatty acid metabolism.
Castro-Gil MP; Torres-Mena JE; Salgado RM; Muñoz-Montero SA; Martínez-Garcés JM; López-Torres CD; Mendoza-Vargas A; Gabiño-López NB; Villa-Treviño S; Del Pozo-Yauner L; Arellanes-Robledo J; Krötzsch E; Pérez-Carreón JI
Genomics; 2022 Jan; 114(1):72-83. PubMed ID: 34861383
[TBL] [Abstract] [Full Text] [Related]
14. Overcoming the compensatory elevation of nrf2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis.
Ren X; Li Y; Zhou Y; Hu W; Yang C; Jing Q; Zhou C; Wang X; Hu J; Wang L; Yang J; Wang H; Xu H; Li H; Tong X; Wang Y; Du J
Redox Biol; 2021 Oct; 46():102122. PubMed ID: 34482117
[TBL] [Abstract] [Full Text] [Related]
15. CDCA2 protects against oxidative stress by promoting BRCA1-nrf2 signaling in hepatocellular carcinoma.
Wang S; Cao K; Liao Y; Zhang W; Zheng J; Li X; Huang M; Zhong Y; Hu X; Chen D; Wang Y
Oncogene; 2021 Jun; 40(25):4368-4383. PubMed ID: 34103686
[TBL] [Abstract] [Full Text] [Related]
16. Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the nrf2 pathway.
Zhao F; Hong X; Li D; Wei Z; Ci X; Zhang S
Med Oncol; 2021 Apr; 38(5):54. PubMed ID: 33811596
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Mechanisms of Hepatoblastoma.
Zhang Y; Solinas A; Cairo S; Evert M; Chen X; Calvisi DF
Semin Liver Dis; 2021 Jan; 41(1):28-41. PubMed ID: 33764483
[TBL] [Abstract] [Full Text] [Related]
18. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK-nrf2 signaling.
Yang Y; Zheng J; Wang M; Zhang J; Tian T; Wang Z; Yuan S; Liu L; Zhu P; Gu F; Fu S; Shan Y; Pan Z; Zhou W
Cancer Sci; 2021 Feb; 112(2):641-654. PubMed ID: 33222332
[TBL] [Abstract] [Full Text] [Related]
19. MiniPDX-guided postoperative anticancer treatment can effectively prolong the survival of patients with hepatocellular carcinoma.
Yang L; Yuan Z; Zhang Y; Cui Z; Li Y; Hou J; Liu X; Liu Z; Shi R; Tian Q; Wang J; Wang L
Cancer Chemother Pharmacol; 2021 Jan; 87(1):125-134. PubMed ID: 33141330
[TBL] [Abstract] [Full Text] [Related]
20. C3a and C5a facilitates the metastasis of myeloma cells by activating nrf2.
Xiong J; Kuang X; Lu T; Yu K; Liu X; Zhang Z; Wang W; Zhao L; Fang Q; Wu D; Wang J
Cancer Gene Ther; 2021 Apr; 28(3-4):265-278. PubMed ID: 32873871
[TBL] [Abstract] [Full Text] [Related]
[Next]
